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CardioprotectionMitochondrial quality control is increasingly recognized as an essential element in maintaining optimally
functioning tissues. Mitochondrial quality control depends upon a balance between biogenesis and autophagic
destruction. Mitochondrial dynamics (fusion and ﬁssion) allows for the redistribution of mitochondrial
components. We speculate that this permits sorting of highly functional components into one end of a
mitochondrion, while damaged components are segregated at the other end, to be jettisoned by asymmetric
ﬁssion followed by selective mitophagy. Ischemic preconditioning requires autophagy/mitophagy, resulting in
selective eliminationof damagedmitochondria, leavingbehindapopulationof robustmitochondriawith ahigher
threshold for opening of the mitochondrial permeability transition pore. In this review we will consider the
factors that regulatemitochondrial biogenesis anddestruction, themachinery involved inboth processes, and the
biomedical consequences associated with altered mitochondrial turnover. This article is part of a Special Issue
entitled: Mitochondria and Cardioprotection.hondria and Cardioprotection.
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Mitochondrial quality control is increasingly recognized as an
essential element in maintaining optimally functioning tissues. Mito-
chondrial quality control depends upon a balance between biogenesis
and autophagic destruction. Our understanding of mitochondrial
turnover is based on 50-year-old studies of radiolabeled mitochondrial
proteins [1] which provided information on the bulk turnover of
mitochondrial proteinsbutno insight into the fate of assembledelectron
transfer complexes or respirasomes. More recent insights into mito-
chondrial biogenesis, ﬁssion, fusion, and autophagy have given support
to the idea that these interconnected processes are essential for
mitochondrial quality control. What are the predictions from the
mitophagy-cardioprotection hypothesis? 1. Any preconditioning inter-
vention will result in a decrease in mitochondrial number. 2.
Mitochondrial number, mass, and function will increase rapidly upon
refeeding, adaptation, or reoxygenation. 3. The newly regenerated
mitochondria will have improved function, will be enriched for
respirasomes, and will display other distinctive characteristics. 4. A
‘bottleneck’will allow selection for the bestmitochondrial DNA genome
and will permit culling to take place. 5. While mitochondrial turnover
may average 17 days (protein half-life) under steady state condi-
tions [2], episodic fasting or repetitive preconditioning will shorten the
half-life. Some evidence exists to support these predictions. Caloricrestriction inducesmitochondrial biogenesis andbioenergetic efﬁciency
[3]. Hypoxia accelerates mitochondrial protein turnover, reﬂecting
increased destruction and biogenesis [4]. Like hypoxia, ischemic
preconditioning is expected to accelerate mitochondrial turnover, as it
was shown that many mitochondrial inner membrane proteins and
heme groups turn over with the same kinetics, reﬂecting destruction
of the entire organelle [5], which has subsequently been shown to be
mediated by autophagy.
In this review we will consider the factors that regulate mitochon-
drial biogenesis and destruction, the machinery involved in both
processes, and the biomedical consequences associated with altered
mitochondrial turnover.2. Mitochondrial biogenesis
The peroxisome proliferator-activated receptor gamma (PPARγ) in
tandem with the retinoic acid receptor (RXR) regulates pathways of
fatty acid oxidation for both mitochondria and peroxisomes. Free fatty
acids and thiazolidinediones are ligands for PPARγ. Mitochondrial
biogenesis is controlled by the PPARγ coactivator (PGC) family of
transcriptional coactivators, most importantly PGC-1α, PGC-1β, and the
PGC-related coactivator PRC. PGC-1α works in tandem with nuclear
respiratory factor 2 (NRF-2) to co-activate NRF-1. The NRFs direct the
transcription of nuclear encodedmitochondrial proteins, themitochon-
drial protein import machinery, and co-factors required for assembly of
the respiratory chain complexes, as well as the regulatory factors
required for mitochondrial DNA transcription and translation, most
importantly mitochondrial transcription factor A (Tfam). Tfam is
important not only for mitochondrial gene transcription but also for
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is sufﬁcient to drive mitochondrial biogenesis [7]. Acetylation of
PGC1α suppresses its transcriptional coactivator activity and can
therefore limit mitochondrial biogenesis despite high levels of protein.
Therefore an important regulator of mitochondrial biogenesis is the
histone deacetylase sirtuin 1 (Sirt1) which can serve to activate
PGC1α and mitochondrial biogenesis [8]. Since sirtuins also regulate
autophagy through FoxO1 and FoxO3, it appears that mitochondrial
removal and resynthesis are linked, at least in the contexts of nutrient
deprivation and oxidative stress, two stimuli that activate Sirt1 in the
heart [9].
3. Mitochondrial dynamics and mitophagy
Mitochondria are highly dynamic organelles and are constantly
undergoing ﬁssion and fusion. Mitochondrial dynamics are regulated
by at least four conserved dynamin-related GTPases. Drp1 and hFis1
are involved in mitochondrial ﬁssion [10,11], and studies in yeast
suggest that Drp1 assembles into rings surrounding the mitochon-
drial outer membrane with the help of hFis1 [12]. Mitochondrial
fusion requiresMitofusins 1 and 2 (Mfn1,Mfn2) in the outer and Opa1
in the inner membrane to control mitochondrial membrane fusion
[13,14]. Fission will produce smaller organelles whereas fusion
produces tubular or net-like structures [15]. Interestingly, mitochon-
drial dynamics not only determines mitochondrial size, but also plays
an essential role in mitochondrial turnover. Mitochondrial ﬁssion is
essential for mitophagy and inhibition of ﬁssion results in disruption
of mitophagy and accumulation of dysfunctional mitochondria
[16,17]. A recent study by Twig et al. showed that regulated ﬁssion
and fusion events help segregate dysfunctional mitochondria prior to
mitophagy. This study found that ﬁssion of mitochondria produced
metabolically different fragments with different Δψm. The fragment
with high Δψm had a high probability of undergoing fusion, whereas
the fragment with low Δψm was more likely to be targeted by
autophagy [16].
Although some of the molecules that control mitochondrial ﬁssion
and fusion are known, new molecules and pathways that control this
process continue to be discovered, suggesting that this process is
more complex than was previously thought. Recently, it has been
reported that the Bcl-2 family proteins may participate in the
regulation of mitochondrial dynamics in healthy cells. For instance,
Karbowski et al. reported that in healthy cells, pro-apoptotic Bax or
Bak is required for normal fusion of mitochondria by activating
assembly of Mfn2 [18]. Bcl-XL was found to perturb mitochondrial
dynamics, where Bcl-XL overexpressing cells displayed either frag-
mented or fused mitochondria networks [19]. Berman et al. recently
conﬁrmed the ﬁnding that Bcl-XL could increase either ﬁssion or
fusion [20]. These studies demonstrate that the Bcl-2 family proteins
have a function that is completely separate from their role as
regulators of outer mitochondrial membrane permeabilization during
apoptosis. However, how these proteins regulate mitochondrial
morphology is not known and needs to be further investigated.
4. Removal of mitochondria is accomplished through
autophagy (mitophagy)
Although individualmitochondrial proteins can be degraded via Lon
protease, other AAA proteases, and even proteasomes located in the
mitochondrialmatrix, the vastmajority of mitochondrial degradation is
accomplished through the autophagy–lysosome pathway, although
some outermembrane proteins are eliminated via the proteasome [21].
While early studies suggested thismight be a non-speciﬁc bulk removal
of cytosolic components, this was soon abandoned as the process was
soon shown to be selective: mitochondria may be removed leaving
endoplasmic reticulum or contractile assemblies intact. Moreover,
mitochondria are not removed randomly: subpopulations of mitochon-dria are removed through complex mechanisms that are still being
delineated. Two important mediators of mitophagy–Nix/Bnip3 and
PINK1/Parkin–will be discussed below.
Mitochondrial ﬁssion, fusion, and autophagy have been shown to be
essential partners in mitochondrial quality control [16]. In our work,
only 10% of autophagosomes colocalize with a mitochondrial marker
at any given time [Yuan, personal communication], yet autophagy
mediates a 70% reduction inmitochondrial number (and surfacearea) in
cells after 3.5 hours of starvation [22]. This suggests that mitophagy is a
very rapid process. Inmice subjected to overnight fasting,we observed a
rapid 50% decrease in the number of mitochondria, accompanied by an
inverse increase in the number of autophagosomes, measured by
ﬂow cytometry of the postnuclear fraction labeled with mCherryLC3
(autophagosomes) and anti-monoamine oxidase B (mitochondria)
(Gottlieb, unpublished data). This surprising result reveals a substantial
degree of mitochondrial turnover in response to a modest fast!
This magnitude and pace of mitochondrial turnover was previously
unsuspected. One consequence of such generalized mitochondrial
destruction is replacement of mitochondria with newer, more efﬁcient
mitochondria. In rats subjected to 50% caloric restriction for one week
followed by one week of re-feeding, the hepatic mitochondria were
shown to be more efﬁcient, evidenced by higher state 3 mitochondrial
respiratory capacity and increased superoxide dismutase activity [23].
Recently we reported myocardial ischemic preconditioning involved
autophagy, and unpublished studies conﬁrm mitochondria to be the
target (Gottlieb, unpublished data). One might wonder whether this
process of mitochondrial culling might result in reduced ATP produc-
tion. If depolarized mitochondria are selected for removal, there
would be little downside: depolarized mitochondria contribute little
to ATP production, and can hydrolyze ATP in a futile effort to restore
mitochondrial membrane potential (Fig. 1). Moreover, there appears to
be signiﬁcant metabolic reserve in the normal heart. Inhibition of
mitochondrial respiration with amytal reduced phosphocreatine con-
tent by 63%, but ATP levels were unchanged. Maximal cardiac output
wasdecreased by30% [24]. However, it appears the heartwould tolerate
a signiﬁcant reduction in mitochondrial content, particularly if the
slackers are the ﬁrst ones to get sacked.
5. Roles of Nix and Bnip3 in mitophagy
Nix/BNIP3L and Bnip3 belong to the BH3-only proteins of the Bcl-2
family. Both Nix and Bnip3 have been implicated in the pathogenesis of
cancer [25–27] and heart disease [28–30]. Similar to other BH3-only
proteins, they contain a BH3 domain [31,32], localize to the mitochon-
dria where they can activate Bax/Bak [33–35], and interact with Bcl-2
and Bcl-XL [31,36]. However, in contrast to other BH3-only proteins, Nix
and Bnip3 have an alternative function to apoptosis They have been
identiﬁed to be important regulators of mitophagy [29,37,38]. For
instance, erythroid cells go through enucleation and removal of
mitochondria during terminal differentiation [39] and the mitochon-
drial clearance via autophagy was dependent on the presence of Nix.
Interestingly, it did not require other BH3-only proteins such as Bim or
Puma [37], suggesting that this function is speciﬁc for Nix. They found
that Nix was not required for the induction of autophagy, but was
required for the selective elimination of mitochondria. Similarly,
Sandoval et al. found that NIX was required for mitophagy in erythroid
cells [40]. Erythrocytes in the peripheral blood of Nix−/−mice exhibited
mitochondrial retention and reduced lifespan in vivo. Similarly, Bnip3
has been reported to induce mitochondrial autophagy. For instance,
overexpression of Bnip3 induced mitophagy in HL-1 cells [29] and
hypoxia-mediated mitophagy required the hypoxia-dependent factor-
1-dependent expression of Bnip3 [41]. Exactly how Nix and Bnip3 ﬂag
mitochondria for autophagy is unclear, but Sandoval et al. proposed that
Nix-dependent loss of Δψm was important in targeting the mitochon-
dria to autophagosomes for clearance during erythroidmaturation [40].
They found that mitophagy was restored when Nix−/− cells were
Fig. 1. The mitochondrial population is heterogeneous with respect to membrane potential and susceptibility to MPTP opening. A stress triggers MPTP in the most vulnerable
mitochondria, which are removed by selective mitophagy. The remaining mitochondria have high membrane potential, lower ROS production, and greater resistance to MPTP
opening.
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In addition, Nix was recently reported to interact directly with the
autophagy proteins LC3 and GABARAP, and to recruit GABARAP to
depolarized mitochondria [42]. This suggests that Nix might be
functioning as a receptor for autophagosomes and that binding of
Nix to LC3 on the autophagosome tethers the mitochondrion to the
autophagosome. It is still unknown how Bnip3 targets mitochondria to
the autophagosomes and if Bnip3 can also act as an autophagy receptor.
Further studies are needed to answer these questions.
6. Roles of Parkin, PINK1 and p62/SQSTM1 in mitophagy
The PTEN-induced kinase 1 (PINK1) and Parkin have been identiﬁed
as important regulators of mitochondrial function and autophagy in
cells. PINK1 is a mitochondrially targeted serine/threonine kinase and
Parkin is an E3 ubiquitin ligase. Loss-of-functionmutations in the genes
coding for PINK1 and Parkin are associated with early-onset familial
Parkinson's disease [43,44]. Studies inDrosophila melanogaster revealed
that PINK1 and Parkin play key roles in regulating mitochondrial
function where loss of function causes striking changes in both
mitochondrial structure and function. For instance, removal of or
mutations in the Drosophila homologue of PINK1 induced mitochon-
drial impairmentwhich resulted inﬂightmuscle degeneration andmale
sterility [45,46]. Similarly, Parkin deﬁcient ﬂies exhibited loss of
dopaminergic neurons and swollen and disordered mitochondria
appearing before degeneration of their ﬂight muscles [47,48]. PINK1
or Parkin deﬁciency in mice also resulted in impaired mitochondrial
respiration and oxidative damage of proteins and lipids which were
exacerbated with aging [49,50]. Several studies have shown that PINK1
functions upstream of Parkin [45,51,52]. For instance, Park et al. found
that PINK1 and Parkin mutants had similar phenotypes and that
overexpressionof Parkin rescued themitochondrial phenotype inPINK1
mutant Drosophila but not vice versa [45].
Recently, PINK1 and Parkin have been identiﬁed to play important
roles in mitochondrial turnover. Narendra et al. reported that Parkin
promoted the clearance of impaired mitochondria by autophagy. They
found that Parkin accumulated on depolarized mitochondria whichpromoted their removal by autophagy [53]. Moreover, translocation of
Parkin tomitochondriawas dependent on PINK1 [54,55]. Knockdownof
PINK1 abolished Parkin recruitment to mitochondria and mitophagy in
response to CCCP treatment [54], whereas overexpression of PINK1
promoted translocation of Parkin to mitochondria with normal Δψm
[55]. Since Parkin is an E3 ubiquitin ligase, it was surprising that Parkin
was found to induce mitophagy by promoting the ubiquitination of
proteins on dysfunctional mitochondria. Also, this study found that
Parkin-mediated ubiquitination served to recruit ubiquitin-binding
deacetylase HDAC6 and p62/SQSTM1, which promotes the assembly of
the autophagy machinery to clear impaired mitochondria [56]. p62/
SQSTM1 targets substrates for autophagy by binding both ubiquitinated
proteins and LC3 on the autophagosome [57]. Geisler et al. found that
p62/SQSTM1 acts as an adaptor protein for Parkin-mediatedmitophagy
where the recruitment of p62/SQSTM1 to poly-ubiquitin-positive
clusters of mitochondria was dependent on functional Parkin [54].
Knockdown of p62/SQSTM1 had no inﬂuence on mitochondrial
translocation of Parkin, but completely blockedmitochondrial clearance
of damaged mitochondria [54]. Thus, p62/SQSTM1 is not required for
Parkin translocation to damagedmitochondria, but is essential for their
ﬁnal autophagic clearance. Similarly, Lee et al. found that Parkin-
mediated ubiquitination served to recruit p62/SQSTM1 and that p62/
SQSTM1-deﬁcient cells were defective in Parkin-dependent mitophagy
[56]. Thus, this suggests that ubiquitination of mitochondrial outer
membrane proteins is a critical basis for the speciﬁc and effective
clearance of mitochondria by autophagy.
Under normal conditions, mitochondria exist as a tubular inter-
connected network. Two separate studies noted that PINK1 and Parkin
disrupted the mitochondrial network and induced aggregation of
mitochondria in the perinuclear region where the fragments were
removed by autophagosomes [55,56]. Mitochondrial transport is
dependent on the microtubule dynein motor and treatment of cells
with the microtubule destabilizing agent nocodazole inhibited both
Parkin-mediated perinuclearmitochondrial aggregation andmitophagy
[55,56]. These studies suggest that transport of mitochondria via the
microtubules to the perinuclear region is an essential step in the
mitochondrial degradation pathway. However, many components are
Fig. 2.During fusion, cycles of assembly and disassembly of electron transfer complexes
and respirasomes results in sorting, so that misfolded proteins are excluded from re-
assembled respirasomes. Regions enriched for respirasomes are shown in darker blue.
Fission takes place where the inner membrane is less rigid, i.e., where there are few
respirasomes. This results in two daughter mitochondria, one with low membrane
potential and defective electron transfer complexes, and another with high membrane
potential and many respirasomes.
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PINK1 and Parkin interacted but there was no evidence that PINK1
phosphorylated Parkin or that Parkin catalyzed PINK1 ubiquitination
[55]. Also, exactly how PINK1 recognizes dysfunctional mitochondria
and how Parkin's E3 ligase activity is activated are still unclear. Thus,
there are still many questions regarding the mechanism of PINK1/
Parkin-mediated mitophagy.
7. Mitochondrial dynamics and respirasome maintenance
Synthesis of nuclear and mitochondrial encoded electron transfer
subunits must be neatly coordinated so that all necessary components
are available for assembly. The electron transfer complexes in turn are
incorporated into larger assemblies, called supercomplexes, or respira-
somes, which represent the optimal functional units of mitochondrial
respiration and ATP production [58]. It is unknown whether super-
complexes undergo reversible assembly and disassembly. However, as
subunits acquire oxidative damage, they must be replaced. Several
scenarios are possible: individual subunits are removed, degraded
(e.g., by Lon or AAA proteases), and replaced asynchronously; super-
complexes undergo dynamic assembly/disassembly, allowing for
incorporation of fully functional complexes into respirasomes and
exclusion of complexes containing damaged subunits; whole mito-
chondria are removed and replaced. The existence of Lon protease and
other AAA proteases suggests that damaged components can be
removed selectively and replaced. One means by which removal of
components and targeted replacement could occur would be through
dynamic assembly and disassembly of respiratory supercomplexes
(respirasomes), which comprise stoichiometrically conserved assem-
blies of respiratory complexes and F0F1 ATPase assemblies in a
paracrystalline array [59]. These assemblies would efﬁciently exclude
misfolded proteins [58]. Indeed, Hoppel's group has shown that in heart
failure, respirasome content diminishes although total content of
mitochondrial electron transfer complexes remains unchanged [60].
Mitochondrial fusion events allow for rapid mixing of matrix contents,
but exchange of inner membrane components occurs on a slower time
scale, based on experiments monitoring the diffusion of photoactivated
GFP (PA-GFP) targeted to matrix or inner mitochondrial membrane
[61]. However, PA-GFP is not incorporated into ox-phos complexes or
respirasomes, and therefore studies using this approach may greatly
overestimate the rate of mixing of electron transfer complexes and
respirasomes. It is conceivable that some components are not
exchanged at all but rather persist for the life of the mitochondrion,
while recently synthesized components are assembled de novo into
new electron transfer complexes and then into respirasomes. Regions
enriched in supercomplexes might have more rigid membrane
architecture and conceivably might be less likely to undergo ﬁssion,
while individual electron transfer complexes not organized into super-
complexes, as well as any misfolded components, would be excluded
and would end up in regions of increased membrane ﬂuidity. When
ﬁssion ensues, the region with supercomplexes would have high
membrane potential, while the other segment would contain isolated
electron transfer complexes and damaged proteins, and would have
lower membrane potential (Fig. 2). Newly synthesized proteins would
be more likely to be imported into the mitochondrion with higher
membrane potential, since protein import is heavily dependent on
membrane potential. This leads to the prediction that some mitochon-
dria would be enriched for newly assembled and highly-functional
respirasomes. This proposed sorting process represents the functional
equivalent of forming a new mitochondrion, something that might be
called mito-neogenesis.
8. Consequences of altered mitochondrial ﬁssion/fusion
Although the physiological roles of mitochondrial fusion and ﬁssion
in cell function and survival are still poorly understood, it is clear thatthese processes are essential for cellular homeostasis. Inhibition of Drp1
suppresses mitophagy, revealing a close linkage between ﬁssion and
mitophagy [16]. Fission and fusion are a dynamic dance essential for
mitochondrial quality control, while autophagy serves to remove the
mitochondria that are no longer competent to participate in fusion.
Mice lacking Mfn1, Mfn2, or Opa1 die at an early embryonic stage
[62,63]. Moreover, in humans, point mutations in Mfn2 and Opa1 lead
to severe neurodegenerative diseases such as Charcot–Marie–Tooth
type 2A and dominant optic atrophy, respectively [64–67]. On the
other hand, deletion of Drp1 is lethal for Caenorhabditis elegans [68],
and a mutation in Drp1 was recently described in an infant with fatal
abnormal brain development [69]. Impaired mitochondrial dynamics
has also been implicated in neurodegenerative diseases including
Parkinson, Alzheimer's and Huntington diseases [70–72]. These
ﬁndings demonstrate the importance of mitochondrial dynamics in
cell homeostasis.
Alterations in mitochondrial dynamics also occur in response to
cellular stress which shifts the balance towards ﬁssion [71,73,74].
Youle and colleges reported that Drp-1 translocated from the cytosol
to deﬁned foci on the mitochondrial membrane where it co-localized
with pro-apoptotic Bax at the onset of apoptosis [75]. They found that
a dominant negative of Drp-1 inhibited ﬁssion and apoptosis, but had
no effect on Bax translocation in response to staurosporine treatment,
suggesting that Bax can induce apoptosis by activating the mitochon-
drial ﬁssion pathway. Moreover, the pro-apoptotic BH3-only protein
EGL-1 induced Drp-1-mediated mitochondrial ﬁssion and apoptosis
during development in C. elegans [74]. However, another study
reported that Bax-induced mitochondrial ﬁssion was not necessarily
linked to cytochrome c release and apoptosis. Overexpression of Bcl-
xL blocked cytochrome c release and apoptosis but did not rescue
mitochondrial fragmentation [19]. There is less information on the
role of ﬁssion/fusion in the heart. Recently, it was reported that
increased mitochondrial ﬁssion plays a role in myocardial ischemia/
reperfusion (I/R) injury [76]. Ong et al. found that enhancing fusion in
HL-1 myocytes by overexpressing mitofusin or inhibiting ﬁssion with
a Drp1 dominant negative protected against simulated I/R-mediated
cell death. Moreover, treatment with an inhibitor of Drp-1 (mDivi-1)
1299R.A. Gottlieb, Å.B. Gustafsson / Biochimica et Biophysica Acta 1813 (2011) 1295–1301reduced I/R injury in vivo [76], although they did not examine
mitochondrial morphology in the treated hearts. Effects of mDivi-1
can be variable, and can lead to fragmentation or fusion [Wikstrom,
personal communication]. Another study found that failing hearts had
reduced OPA1 protein levels and myocytes contained small fragmen-
ted mitochondria [77]. Interestingly, overexpression of OPA1 in-
creased mitochondrial fusion but did not protect against simulated I/
R-mediated cell death in H9c2 cells [77]. Overexpression of Opa1 can
have variable effects, favoring fusion when expressed at low to
moderate levels, and driving ﬁssion when expressed at higher levels
[78]. Experimental variability may also arise from the differences in
the experimental cell models (HL-1 cells vs. H9c2 cells.) Whether the
proteins governing ﬁssion and fusion have additional functions is
unclear but must be considered when evaluating the literature.
Clearly, an imbalance in ﬁssion or fusion due to genetic mutation or in
response to stress can be detrimental to the cell. Overexpression of
ﬁssion proteins leads to extensive ﬁssion of mitochondria, can induce
excessive mitochondrial autophagy, and in some cases can trigger
apoptosis [79]. In general, overexpression of fusion proteins leading to
enhanced mitochondrial networking protects cells from certain
apoptotic stimuli. It is not clear whether overexpression of fusion
proteins prevents removal of dysfunctional mitochondria by autop-
hagy, but it has been noted that megamitochondria are not eliminated
even when they appear to be damaged [80].
9. Metabolic reprogramming through mitophagy and biogenesis
Metabolic reprogramming occurs during cell differentiation, as for
example when a stem cell with relatively modest energy needs
differentiates into a cardiomyocytewith exceedingly high ATP synthetic
requirements. The mitochondrial electron transfer complexes, PDH
complex, and fatty acid transport systems (CPT-I and -II)mustbealtered
to meet the different needs of the cardiomyocyte, a process requiring
assembly of complexes containing different subunit isoforms in the
mitochondria. While it is possible that this is conducted in a piecemeal
fashion, considerable evidence supports the notion that most mito-
chondria are eliminatedandawaveofmitochondrial biogenesis follows,
during which time the new isoforms are expressed and incorporated
into the assembling complexes. In the context of cardioprotective
signaling, nitric oxide activates autophagy andmitochondrial biogenesis
[81]. Autophagy andmitochondrial biogenesis share common signaling
pathways [82]. If this is the case, then it follows that autophagymay be a
prerequisite for effective mitochondrial biogenesis during metabolic
reprogramming and potentially in the more general context of cellular
homeostasis over the Circadian cycle. It is known that many ox-phos
genes are expressed differentially in the heart over the 24-hr cycle,
reﬂecting differential needs for ATP production during active and sleep
phases [83]. Whether a subset of mitochondria are newly assembled
each day, or whether individual subunits are swapped out as needed
remains to be established. However, it seems likely that even in
terminally differentiated adult cardiomyocytes, a sizeable number of
mitochondria must turn over on a daily basis (otherwise the changes in
mRNA would be negligible).
10. Mitophagy and cardioprotection
Our studies and those of others have implicated autophagy in
cardioprotection [84,85], and we have shown that autophagy is
essential for cardioprotection [86–89]. How might preconditioning
trigger autophagy andmitophagy? Opening of themitochondrial ATP-
sensitive potassium channel (mitoKATP) or transient opening of the
mitochondrial permeability transition pore has been proposed as
mechanisms of preconditioning. One feature shared by these two
phenomena is mild depolarization of the mitochondrial inner
membrane. Given that mitochondrial depolarization prevents mito-
chondrial fusion and will signal for autophagic removal, it seemsreasonable to propose that preconditioning may operate through
mitophagy. Mitophagy (selective autophagy of mitochondria) has
been described by many groups [29,86,90–93], and is known to occur
in response to ischemic stress. Autophagy is required to eliminate
damaged mitochondria; removal of mitochondria that are producing
ROS would prevent dissemination of injury to neighboring mitochon-
dria and thereby prevent wholesale mitochondrial permeability
transition pore opening. A universal feature of myocardial precondi-
tioning is preservation of ATP stores, calcium homeostasis, and
mitochondrial integrity [94,95]. The mitochondria that remain after
autophagic culling would be predicted to exhibit higher functionality
and a distinctive proteomic proﬁle. Consistent with this notion,
Hausenloy reported that mitochondria isolated from preconditioned
hearts have a higher threshold for permeability transition pore
opening [95], while distinctive changes in the post-translational
modiﬁcations of several mitochondrial proteins were observed after
pharmacologic preconditioning [96].
It is worth noting that preconditioning is impaired in conditions in
which autophagy is also diminished, including diabetes and advanced
age, again supporting the idea that the two processes are linked.11. Perspectives
Recent studies reveal that starvation results in a profound
reduction in mitochondrial number, which is followed by vigorous
mitochondrial biogenesis upon refeeding. This cycle of destruction
and resynthesismay allow for culling of the least-ﬁt mitochondria, but
also permits metabolic reprogramming of mitochondria [97]. It seems
reasonable to propose that cycles of intermittent fasting and resultant
mitophagy may represent critical elements of mitochondrial quality
control essential to cardiac health.
Mitophagy may be relevant to more than just preconditioning; it
could be an important element in lifespan extension, where periodic
removal of poor-quality mitochondria would enable their replacement
with new, more efﬁcient ones. This could be compared to eliminating
10% of the oil-burning clunkers on the freeway and replacing themwith
fuel-efﬁcient hybrids. Themore often clunkers are removed, the quicker
the ﬂeet can be cleaned up, as long as production can match demand.
Empiric studies have shown that alternate day fasting results in
substantial lifespan extension; thus under normal conditions, produc-
tion can keep up with alternate-day destruction. Caloric restriction or
alternate-day fasting has been shown to confer cardioprotection.
Cardioprotection may therefore reﬂect mitochondrial quality. Autop-
hagy induced by caloric restriction is closely linked to longevity [98,99],
and this may be due to the episodic culling of inefﬁcient mitochondria
followed by their replacement with new mitochondria.
It is important to understand the mechanistic relationship
between caloric restriction, autophagy, mitochondrial quality, cardiac
health and longevity. Developing better tools to monitor mitochon-
drial turnover will yield new insights into the cellular processes that
determine mitochondrial function and oxidative stress, which are key
determinants of cardiac function and longevity.Acknowledgments
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